| |
[Gln 4]-Neurotensin  |
|
|

| Cat. No. |
Size |
Price |
Figures |
RP10447-1 mg
| 1 mg | $ 23.75 | HPLC: 20060721145616 (PDF) MS: 20060721145555 (PDF) MSDS: 20080923040253 (PDF)
References:
- Karaus M, et al. Differential effects of [Gln4]neurotensin on circular and longitudinal muscle of dog ileum in vitro. Am. J. Physiol. Oct 1987; 253(4 Pt 1):G566-572.
- Folkers K, et al. Synthesis and activities of neurotensin, and its acid and amide analogs: possible natural occurrence of [Gln4]-neurotensin. Proc. Natl. Acad. Sci. USA. Nov 1976; 73(11): 3833-3837.
- Li N, et al. Inhibition of mitochondrial gene transcription suppresses neurotensin secretion in the human carcinoid cell line BON. Am J Physiol Gastrointest Liver Physiol. Feb 2005; 288(2): G213-220.
|
|---|
| Full Name | |
Sequence (one-letter code) |
ELYQNKPRRPYIL | Sequence (three-letter code) | {GLU}{LEU}{TYR}{GLN}{ASN}{LYS}{PRO}{ARG}{ARG}{PRO} {TYR}{ILE}{LEU} | | Description | [Gln4]neurotensin has differential effects on isolated muscle strips of the two muscle layers in the dog ileum. [Gln4]neurotensin stimulates the circular muscle partially through cholinergic nerves at preganglionic sites and partially through a direct myogenic effect. [Gln4]neurotensin inhibits the spontaneous activity of the longitudinal muscle presumably by reducing the excitability of cholinergic nerves at postganglionic sites. |
|---|
| Formula | C78H124N22O20 | | M.W. | 1689.96 | | Purity | > 95% | | Storage | Store at -20°C. |
| * For Non-Clinical Research Use Only *
Our customer service is available 24 hours a day, Monday through Friday. You may contact us any time for assistance.
|
|